Consolidated Statement Of Cash Flows

KOBAYASHI PHARMACEUTICAL CO.,LTD. - Filing #7722876

Concept 2018-01-01 to
2018-06-30
As at
2018-06-30
As at
2017-12-31
As at
2017-06-30
2017-01-01 to
2017-06-30
As at
2016-12-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
10,108,000,000 JPY
12,120,000,000 JPY
Interest and dividends received
349,000,000 JPY
310,000,000 JPY
Interest paid
-1,000,000 JPY
-7,000,000 JPY
Income taxes paid
-4,037,000,000 JPY
-3,232,000,000 JPY
Net cash provided by (used in) operating activities
6,418,000,000 JPY
9,191,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-1,884,000,000 JPY
-1,528,000,000 JPY
Proceeds from sale of property, plant and equipment
0 JPY
1,000,000 JPY
Purchase of investment securities
-11,000,000 JPY
-1,048,000,000 JPY
Net cash provided by (used in) investing activities
-7,618,000,000 JPY
4,813,000,000 JPY
Proceeds from sale of investment securities
2,000,000 JPY
5,000,000 JPY
Purchase of shares of subsidiaries resulting in change in scope of consolidation
-1,834,000,000 JPY
JPY
Other, net
JPY
-50,000,000 JPY
Cash flows from financing activities
Purchase of treasury shares
JPY
-5,068,000,000 JPY
Dividends paid
-2,368,000,000 JPY
-2,134,000,000 JPY
Net cash provided by (used in) financing activities
-2,035,000,000 JPY
-7,025,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
-398,000,000 JPY
-231,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-3,633,000,000 JPY
6,746,000,000 JPY
Cash and cash equivalents
45,054,000,000 JPY
48,688,000,000 JPY
35,069,000,000 JPY
28,322,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.